GFAP and Alzheimer disease: The ANOVA results of this study indicate that compared to HC group, the elevated levels of blood NfL and GFAP in patients with MCI and AD are statistically significant (PNfL < 0.05, PGFAp < 0.01); thus suggesting their potential use as diagnostic markers.